The BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a chromatographic immunoassay with an instrumented read for the direct and qualitative detection of RSV fusion protein from a direct nasopharyngeal swab from patients suspected of having a viral respiratory infection.

This test is intended for in vitrodiagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients under the age of 6 years.

Negative results do not preclude RSV infection and should not be used as the sole basis for treatment or for other management decisions.

A negative test is presumptive.

It is recommended that negative test results be confirmed by viral cell culture or an alternative method, such as a FDA-cleared molecular assay.

Outside the U.S., a negative test is presumptive and it is recommended that these results be confirmed by viral culture or a molecular assay cleared for diagnostic use in the country of use.

FDA has not cleared this device for use outside of the U.S.

Negative test results do not preclude viral infection and should not be used as the sole basis for treatment or other patient management decisions.

The test is intended for professional and laboratory use.

It is to be used in conjunction with the BD Veritor System Reader.